Literature DB >> 19811957

[Progressive familial intrahepatic cholestasis presenting as liver failure].

A Sangorrin Iranzo1, M Iriondo Sanz, L Alvarez García, P Jara Vega, J Martín de Carpi.   

Abstract

Progressive familial intrahepatic cholestasis (PFIC) is a heterogeneous group of autosomic-recessive inherited cholestatic disorders that begin in the neonatal period or in the first years of life. There are three types of PFIC defined by different mutations located in the gene responsible for the bile flow through the intrahepatic canalicular transporter system. These disorders usually present in children or young adults and the main clinical manifestations are cholestasis, jaundice and pruritus, and they progress slowly towards liver fibrosis in adult life. PFIC diagnosis is based on clinical suspicion, biochemical findings (that include normal gamma-glutamyl transpeptidase in type 1 and 2, but increased levels in type 3), image techniques that rule-out other disorders, and histological confirmation. Initial treatment consists of symptomatic relief of cholestatic symptoms with choleretic agents (urso-deoxycholic acid). Partial biliary derivation and ileal bypass are intermediate therapeutic options. In case of no response to these treatments, liver transplantation is indicated. We report the case of a neonate with PFIC type 2 presenting as a liver failure.

Entities:  

Mesh:

Year:  2009        PMID: 19811957     DOI: 10.1016/j.anpedi.2009.08.005

Source DB:  PubMed          Journal:  An Pediatr (Barc)        ISSN: 1695-4033            Impact factor:   1.500


  3 in total

1.  Orthotopic liver transplantation in a pediatric patient with progressive intrahepatic cholestasis: a coordinated perioperative subspecialty approach.

Authors:  Donald R Ganier; Jimmie E Colón
Journal:  Ochsner J       Date:  2011

Review 2.  Progressive familial intrahepatic cholestasis.

Authors:  Anshu Srivastava
Journal:  J Clin Exp Hepatol       Date:  2013-11-23

3.  Liver transplantation for decompensated liver cirrhosis caused by progressive familial intrahepatic cholestasis type 3: A case report.

Authors:  Deng Xiang; Jiannan He; Hongmei Wang; Fangfang Xiong; Hao Cheng; Junhua Ai; Renfeng Shan; Renhua Wan; Lunli Zhang; Jun Shi
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.